South Korea · Delayed Price · Currency is KRW Englewood Lab Statistics
Total Valuation
Englewood Lab has a market cap or net worth of KRW 225.50 billion. The enterprise value is 202.68 billion.
| Market Cap | 225.50B |
| Enterprise Value | 202.68B |
Important Dates
The next estimated earnings date is Friday, May 8, 2026.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Englewood Lab has 19.87 million shares outstanding. The number of shares has decreased by -0.84% in one year.
| Current Share Class | 19.87M |
| Shares Outstanding | 19.87M |
| Shares Change (YoY) | -0.84% |
| Shares Change (QoQ) | -0.97% |
| Owned by Insiders (%) | 5.74% |
| Owned by Institutions (%) | 0.01% |
| Float | 3.48M |
Valuation Ratios
The trailing PE ratio is 9.07.
| PE Ratio | 9.07 |
| Forward PE | n/a |
| PS Ratio | 1.04 |
| PB Ratio | 1.37 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | 14.38 |
| P/OCF Ratio | 10.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.76, with an EV/FCF ratio of 12.92.
| EV / Earnings | 8.17 |
| EV / Sales | 0.93 |
| EV / EBITDA | 4.76 |
| EV / EBIT | 5.42 |
| EV / FCF | 12.92 |
Financial Position
The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.16.
| Current Ratio | 3.55 |
| Quick Ratio | 2.68 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.61 |
| Debt / FCF | 1.66 |
| Interest Coverage | 32.31 |
Financial Efficiency
Return on equity (ROE) is 16.09% and return on invested capital (ROIC) is 18.32%.
| Return on Equity (ROE) | 16.09% |
| Return on Assets (ROA) | 10.95% |
| Return on Invested Capital (ROIC) | 18.32% |
| Return on Capital Employed (ROCE) | 21.06% |
| Weighted Average Cost of Capital (WACC) | 6.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.02 |
| Inventory Turnover | 3.93 |
Taxes
In the past 12 months, Englewood Lab has paid 10.93 billion in taxes.
| Income Tax | 10.93B |
| Effective Tax Rate | 30.58% |
Stock Price Statistics
The stock price has increased by +35.21% in the last 52 weeks. The beta is 0.46, so Englewood Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +35.21% |
| 50-Day Moving Average | 12,395.80 |
| 200-Day Moving Average | 12,683.65 |
| Relative Strength Index (RSI) | 39.68 |
| Average Volume (20 Days) | 101,459 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Englewood Lab had revenue of KRW 216.79 billion and earned 24.81 billion in profits. Earnings per share was 1,252.00.
| Revenue | 216.79B |
| Gross Profit | 59.90B |
| Operating Income | 37.37B |
| Pretax Income | 35.75B |
| Net Income | 24.81B |
| EBITDA | 42.60B |
| EBIT | 37.37B |
| Earnings Per Share (EPS) | 1,252.00 |
Balance Sheet
The company has 48.82 billion in cash and 26.00 billion in debt, with a net cash position of 22.82 billion or 1,148.58 per share.
| Cash & Cash Equivalents | 48.82B |
| Total Debt | 26.00B |
| Net Cash | 22.82B |
| Net Cash Per Share | 1,148.58 |
| Equity (Book Value) | 164.59B |
| Book Value Per Share | 8,364.78 |
| Working Capital | 126.63B |
Cash Flow
In the last 12 months, operating cash flow was 22.39 billion and capital expenditures -6.71 billion, giving a free cash flow of 15.68 billion.
| Operating Cash Flow | 22.39B |
| Capital Expenditures | -6.71B |
| Depreciation & Amortization | 5.23B |
| Net Borrowing | -4.48B |
| Free Cash Flow | 15.68B |
| FCF Per Share | 789.44 |
Margins
Gross margin is 27.63%, with operating and profit margins of 17.24% and 11.45%.
| Gross Margin | 27.63% |
| Operating Margin | 17.24% |
| Pretax Margin | 16.49% |
| Profit Margin | 11.45% |
| EBITDA Margin | 19.65% |
| EBIT Margin | 17.24% |
| FCF Margin | 7.23% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 0.89%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 0.89% |
| Dividend Growth (YoY) | 95.15% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 8.04% |
| Buyback Yield | 0.84% |
| Shareholder Yield | 1.71% |
| Earnings Yield | 11.00% |
| FCF Yield | 6.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Englewood Lab has an Altman Z-Score of 4.84 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.84 |
| Piotroski F-Score | 7 |